Accès ouvert
2026
article
OpenAlex
Jonah Clegg, Giovanni Cova, Alberto Carignano, Megan Smith et autres
ABSTRACT Staphylococcus aureus is a leading cause of skin and soft tissue infections (SSTIs), yet the cellular mediators of protective memory remain incompletely defined. Using a self‐resolving murine SSTI model, we combined longitudinal single‐cell RNA sequencing with flow cytometry to characterize immune …
ie, it, us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Edoardo Cherubini, Andrea Paola Mandelli, Lucia Henrici De Angelis, Michela Brazzoli et autres
The study of host-pathogen interactions in animal infection models has clarified mechanisms of bacterial pathogenicity and supported the development of preventive and therapeutic strategies. Although many virulence factors have been identified in vivo using mammals such as mice and rats, this work …
it
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Eugene Athan, Richard Neil Greenberg, David Baker, Ruchir Shah et autres
BACKGROUND: A vaccine that prevents Staphylococcus aureus skin and soft tissue infections (SA-SSTIs) would have a major impact on public health. METHODS: A two-part randomized study began with a phase 1, first-in-human, dose-escalation that tested the safety of the five-antigen S. aureus …
au, us, in, Afrique du Sud, gb
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Serena Vastola, Marco Tortoli, Stefania Torricelli, Michela Brazzoli et autres
ABSTRACT Staphylococcus aureus is a pathobiont whose primary human reservoirs are nares, pharynx, intestines, and skin. When specific conditions in the host are altered, it can cause a wide variety of human diseases, including bacteremia and sepsis. Preclinical in vivo models mimicking …
it
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Marco Spinsanti, Elisabetta Monaci, Giacomo Romagnoli, Giada Buffi et autres
Gonorrhea, caused by Neisseria gonorrhoeae (GC) represents a significant public health threat that may be mitigated by an effective vaccine. Vaccines containing N. meningitidis outer membrane vesicles (OMVs), such as 4CMenB, demonstrated moderate effectiveness in preventing GC infections. Here, we developed NgG, …
Accès ouvert
2025
article
OpenAlex
Jonah Clegg, Malgorzata Ewa Mnich, Alberto Carignano, Giovanni Cova et autres
Staphylococcus aureus poses an enormous burden of morbidity and mortality worldwide. Making an efficacious vaccine has however proven extremely challenging. Due to colonizing interactions, pre-existing S. aureus -specific CD4 + T cells are often found in the human population and yet a …
ie, nl
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Sonia Budroni, Marianna Taccone, Maria Laura Stella, Susanna Aprea et autres
BACKGROUND: We determined the relationships between cytokine expression in sputum and clinical data to characterize and understand chronic obstructive pulmonary disease (COPD) exacerbations in people with COPD. METHODS: We measured 30 cytokines in 936 sputum samples, collected at stable state and exacerbation …
in, be, it, us, ch, gb
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Andrea Paola Mandelli, Greta Magri, Marco Tortoli, Stefania Torricelli et autres
Skin and soft tissue infections (SSTIs) are the most common diseases caused by Staphylococcus aureus (S. aureus), which can progress to threatening conditions due to recurrences and systemic complications. Staphylococcal protein A (SpA) is an immunomodulator antigen of S. aureus, which allows …
it, us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Serena Tondi, Emilio Siena, Ahmed Essaghir, Benoît Bozzetti et autres
Shigellosis, an acute gastroenteritis infection caused by Shigella species, remains a public health burden in developing countries. Recently, many outbreaks due to Shigella sonnei multidrug-resistant strains have been reported in high-income countries, and the lack of an effective vaccine represents a major …
it
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Bruna Clemente, Maxime Denis, Camila Pedroso Silveira, Francesca Schiavetti et autres
With the deepening of our understanding of adaptive immunity at the cellular and molecular level, targeting antigens directly to immune cells has proven to be a successful strategy to develop innovative and potent vaccines. Indeed, it offers the potential to increase vaccine …
Accès ouvert
2023
article
OpenAlex
Michela Brazzoli, Diego Piccioli, Federico Marchetti
Antimicrobial resistance (AMR) is considered by WHO one of the top ten public health threats. New control strategies involving concerted actions of both public and private sectors need to be developed. Vaccines play a major role in controlling the spread of AMR …
it
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Emilio Siena, Francesca Schiavetti, Erica Borgogni, Marianna Taccone et autres
The candidate Adjuvant System AS37 contains a synthetic toll-like receptor agonist (TLR7a) adsorbed to alum. In a phase I study (NCT02639351), healthy adults were randomised to receive one dose of licensed alum-adjuvanted meningococcal serogroup C (MenC-CRM197) conjugate vaccine (control) or MenC-CRM197 conjugate …
it, be, ch, us, by
(code pays fourni par la source)